Difference between revisions of "2015-10-07 PLA WGM Agenda"
Jump to navigation
Jump to search
Anne wizauer (talk | contribs) |
Anne wizauer (talk | contribs) (→Agenda) |
||
Line 84: | Line 84: | ||
========================================================---> | ========================================================---> | ||
===Agenda=== | ===Agenda=== | ||
− | Agenda review | + | *Agenda review |
+ | *Notes of [[20150916_PLA_call]] review | ||
*Discussion Topics: | *Discussion Topics: | ||
**Summary of discussions this week with FGB regarding FGB/SGB roles | **Summary of discussions this week with FGB regarding FGB/SGB roles | ||
Line 91: | Line 92: | ||
***Identify current groups handling methodology and determine if they are willing to take on role | ***Identify current groups handling methodology and determine if they are willing to take on role | ||
− | |||
*notional division of products into product families and lines, to provide examples for peer review. | *notional division of products into product families and lines, to provide examples for peer review. | ||
**Level of granularity | **Level of granularity |
Revision as of 16:22, 1 October 2015
return to HL7 Product Line Architecture Meeting Minutes and Agendas
Return to HL7 Product Line Architecture Program
HL7 PLA Call Minutes Location: Conference Room 127 |
Date: 2015-10-07 Time: 3:30 PM Eastern | ||
Facilitator | Mary Kay/ Austin | Note taker(s) | Anne |
Attendee | Name
| ||
Calvin Beebe | |||
Woody Beeler | |||
Lorraine Constable | |||
Bo Dagnall | |||
Regrets | Jean Duteau, | ||
Rick Haddorff | |||
Tony Julian | |||
Paul Knapp | |||
Austin Kreisler, | |||
Lynn Laakso | |||
Mary Kay McDaniel | |||
Brian Pech | |||
John Quinn | |||
John Roberts | |||
Regrets | Andy Stechishin | ||
no quorum definition |
Agenda
- Agenda review
- Notes of 20150916_PLA_call review
- Discussion Topics:
- Summary of discussions this week with FGB regarding FGB/SGB roles
- Update on PLA/SGB presentation to TSC on Saturday
- Next focus: Product management groups
- Identify current groups handling methodology and determine if they are willing to take on role
- notional division of products into product families and lines, to provide examples for peer review.
- Level of granularity
- Identify which pieces are orphaned, and the political elements to be surfaced.
- Positioning cross-product family artifacts (standards naming)
- BAM-lite feedback and review
- Governance on V2.x (v2.9 substantive changes)
- develop form to request establishing a Product Family
Minutes
Convened
Adjourned
Meeting Outcomes
Actions
|
Next Meeting/Preliminary Agenda Items |
© 2014 Health Level Seven® International. All rights reserved